Alcon Aktsia

Alcon CapEx/OCF

CapEx operatiivse rahavoo suhe ettevõttest Alcon (ALC.SW) seisuga 24. aug 2026 on 23,91 %. Eelmisel aastal oli CapEx operatiivse rahavoo suhe 32,26 % — muutus −25,88% (madalam).

CapEx/OCF

23,91 %

YoY

−25,88%

Viimati uuendatud:

CapEx operatiivse rahavoo suhe ettevõttest Alcon on 2026 23,91 % . CapEx operatiivse rahavoo suhe ettevõttest Alcon oli 2025 32,26 % . See väheneb −25,88% madalam võrreldes eelmise aastaga.

Alcon CapEx/OCF ajalugu

  • 3 aastat

  • 10 aastat

  • 25 aastat

  • Max

CapEx/OCF
Date
CapEx/OCF
1. jaan 2018
62,46 USD
1. jaan 2019
73,48 USD
1. jaan 2020
68,89 USD
1. jaan 2021
87,73 USD
1. jaan 2022
61,22 USD
1. jaan 2023
61,31 USD
1. jaan 2024
32,26 USD
1. jaan 2025
23,91 USD
Alcon CapEx/OCF ajalugu
AASTACapEx/OCFYoY
23,91 %−25,88%
32,26 %−47,39%
61,31 %+0,16%
61,22 %−30,22%
87,73 %+27,34%
68,89 %−6,24%
73,48 %+17,65%
62,46 %+53,37%
40,72 %+0,20%
40,64 %+24,84%
32,55 %
Access this data via the Eulerpool API

Alcon Aktsiate analüüs

Mida Alcon teeb? Alcon AG is a leading company in ophthalmology with more than 70 years of experience in this industry. The company was founded in 1945 by Robert Alexander and William Conner and has its headquarters in Geneva, Switzerland. Alcon AG has been part of the Novartis Group since 2019 and is a leader in the production of ophthalmic products. The business model of Alcon AG is based on the manufacturing and sale of ophthalmic products. The company offers medical products such as contact lenses, surgical instruments, eye drops, and intraocular lenses. Alcon AG specializes in the development of products that can be used for various eye diseases. The company provides a wide range of products that can be used by ophthalmologists and opticians. The various divisions of Alcon AG include eye care products, surgical products, and diagnostic products. Eye care products, such as contact lenses, offer consumers a safe and easy way to correct their vision. Surgical products include a wide range of instruments used in eye surgeries. Diagnostic products help identify eye diseases and support treatment. Alcon AG specializes in the development of products for the treatment of eye diseases. These include conditions such as cataracts, glaucoma, and age-related macular degeneration. The company offers various products that can be used for these conditions, such as eye drops to reduce elevated eye pressure in glaucoma. It has also developed a wide range of products for refractive correction, allowing people to improve their vision. Alcon AG works closely with leading ophthalmologists and opticians to optimize its product development. This close collaboration ensures that Alcon AG's products meet the needs of patients and provide them with high safety and effectiveness. With its innovative products and technologies, Alcon AG aims to improve the quality of life for patients and provide them with optimal care and treatment. Overall, Alcon AG is a leading company in ophthalmology, offering its customers a wide range of innovative and high-quality products. From diagnosis to care to surgical interventions, Alcon AG's product range covers all areas of ophthalmology. The company is known for its research and development and is constantly working towards advancing ophthalmology. Through its continuous innovation and customer orientation, Alcon AG has established a strong position in the healthcare industry and will continue to introduce new products and technologies in the future. Alcon on üks populaarsemaid ettevõtteid Eulpoolist.

Sageli esitatud küsimused Alcon aktsia kohta

Alcon CapEx operatiivse rahavoo suhe on 2026. aastal 23,91 %.

CapEx operatiivse rahavoo suhe ettevõttest Alcon muutus 32,26 % -st 23,91 % -ks, mis vastab −25,88% muutusele. Väärtus on madalam kui eelmisel aastal.

Eulpoolist leiate CapEx operatiivse rahavoo suhe Alcon täieliku ajaloolise arengu alates 2006. aastast – koos aastate väärtustega, graafikutega ja üksikasjalike analüüsidega.

CapEx/OCF suhe näitab, kui suur osa operatiivse rahavoo osast reinvesteeritakse kapitalivara. Madamad suhted näitavad rohkem vaba rahavoogu aktsionäridele.

Hea väärtus varieerub tööstuse ja ettevõtte arenguetapi järgi. Eulpoolis saate CapEx operatiivse rahavoo suhe Alcon võrrelda sektori konkurentidega ja tööstuse keskmisega, et hinnata selle atraktiivsust.

CapEx operatiivse rahavoo suhe hindamiseks on oluline võrrelda seda sama tööstuse ja sektori ettevõtetega. Eulpoolis leiate CapEx operatiivse rahavoo suhe jaoks otsesed tööstusesisesed võrdlused.

Access this data via the Eulerpool API

Rahavoog — Alcon

Kõik finantsnäitajad — Alcon